Frontiers in Oncology | Genitourinary Oncology

Original Research

Published on 15 Aug 2025

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure metastatic castration-resistant prostate cancer

in Genitourinary Oncology

Zhiyu Zhang
Yanhang Yu
Chuanao Zhang
Jianglei Zhang
Xuefeng Zhang
Jun Ouyang

Frontiers in Oncology

doi 10.3389/fonc.2025.1608786

372 views

Original Research

Accepted on 13 Aug 2025

Comprehensive analysis of MGLL as a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma

in Genitourinary Oncology

Chen Chen
Zhuojing Hu
Wei Zhao
Yunbo Ma
Qinghua Xia

Frontiers in Oncology

doi 10.3389/fonc.2025.1594540

127 views

Case Report

Published on 13 Aug 2025

Case report: Synchronous bladder and retroperitoneal paragangliomas: an extremely rare entity

in Genitourinary Oncology

Weitao Huang
Yiming Liu
Miaoping Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1593934

244 views

Case Report

Accepted on 12 Aug 2025

Pembrolizumab and Enfortumab Vedotin in Plasmacytoid Urothelial Carcinoma: A Case Series

in Genitourinary Oncology

Susanna Goggans
Derek Allison
Patrick Hensley
Zin W Myint

Frontiers in Oncology

doi 10.3389/fonc.2025.1608291

156 views

Original Research

Accepted on 11 Aug 2025

A novel prognostic biomarker DUSP6 promote the malignant progression of bladder cancer through mTOR mediated mitophagy

in Genitourinary Oncology

Jian Biao Jian Huang
Chongwei Zhou
Zhao Jun Yu
Zhen Song
Huanhuan Deng
HAICHAO CHAO
Tao Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1603069

115 views

Original Research

Accepted on 11 Aug 2025

Multimodal Prognostic Models for Bladder Urothelial Carcinoma: Uroplakin III Combined with Serum and Demographic Data

in Genitourinary Oncology

Runlin Feng
Hou Jian
Yanping Tao
Yu-Min Wang
Songzhou Li
Xingyuan Dong
Tai Wenlin

Frontiers in Oncology

doi 10.3389/fonc.2025.1636358

218 views

Case Report

Published on 11 Aug 2025

Significant response to toripalimab plus axitinib for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report and literature review

in Genitourinary Oncology

Xin Chen
Gonglin Tang
Weicheng Sun
Chengyue Liu
JunDong Zhao
Hongwei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1606414

666 views

Case Report

Published on 11 Aug 2025

Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review

in Genitourinary Oncology

Pichayut Nithagon
Joeffrey Chahine
Lambros Stamatakis
Rashmi Samdani

Frontiers in Oncology

doi 10.3389/fonc.2025.1605192

232 views

Case Report

Accepted on 08 Aug 2025

Case Report: Complete Response to Preoperative Ipilimumab and Nivolumab Combination Therapy in Advanced Papillary Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus and Multiple Metastases

in Genitourinary Oncology

Chika Nagahisa
Kazuhiko Yoshida
Shuhei Nozaki
Shinsuke Mizoguchi
Hironori Fukuda
Yuki Kobari
Junpei Iizuka
Yoji Nagashima
Hideki Ishida
Toshio Takagi

Frontiers in Oncology

doi 10.3389/fonc.2025.1547387

517 views

Correction

Accepted on 08 Aug 2025

Correction: MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590

in Genitourinary Oncology

Chia-Chang Wu
YUAN-HUNG WANG
Su-Wei Hu
Wen-Ling Wu
Chi-Tai Yeh
Oluwaseun Adebayo Bamodu

Frontiers in Oncology

doi 10.3389/fonc.2025.1667245

174 views

Systematic Review

Accepted on 08 Aug 2025

A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer

in Genitourinary Oncology

Massimo Di Maio
Enrique Gonzalez-Billalabeitia
Laura Marandino
Pablo Maroto
Marc-Olivier Timsit
Irene Luccarini
Paul Robinson
Suzy Van Sanden
Boris A. Hadaschik

Frontiers in Oncology

doi 10.3389/fonc.2025.1468928

136 views

Systematic Review

Published on 08 Aug 2025

Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1–4 mutated solid tumors

in Genitourinary Oncology

Jiyu Huang
Zihan Wang
Fei Zhao
Adilai Aisa
Shengkai Tian
Siyuan Chen
Lianyi Peng
Xiaolu Yang
Jianxin He
Yue Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1571434

346 views

Case Report

Published on 07 Aug 2025

Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma—a promising innovative approach

in Genitourinary Oncology

Benjamin Gesundheit
Chaim Brauns
Thomas J. Vogl
Alexander Muckenhuber
Christine Weisslein
Harald Schmoll
Ronald Ellis
Yehudit Posen
Jayadeepa Srinivas Raju

Frontiers in Oncology

doi 10.3389/fonc.2025.1631155

529 views

Original Research

Accepted on 06 Aug 2025

Biparametric MRI-based Radiomics for Differentiating Clinically Significant Prostate Cancer Among Prostate-specific Antigen Level of Gray Zone

in Genitourinary Oncology

Yugang Ji
Wei Liu
Houdong Liu
Jing Wen

Frontiers in Oncology

doi 10.3389/fonc.2025.1615005

Systematic Review

Published on 06 Aug 2025

Comparative efficacy of holmium laser versus plasma techniques in the surgical management of non-muscle invasive bladder cancer: a meta-analysis

in Genitourinary Oncology

Dong Li
Jia-Neng Xu
Han-Kai Chen
Qiang Ren
Yu-Min Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1625901

351 views

Original Research

Published on 06 Aug 2025

A multi-data fusion deep learning model for prognostic prediction in upper tract urothelial carcinoma

in Genitourinary Oncology

Hongdi Sun
Siping Chen
Yongxing Bao
Fengyan You
Honghui Zhu
Xin Yao
Lianguo Chen
Jiangwei Miao
Fanggui Shao
Xiaomin Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1644250

412 views